Eileen White is a cancer scientist who discovered that a DNA tumor virus oncogene<\/a> acts by blocking planned cell death via apoptosis and is a homolog of the human BCL-2 oncogene<\/a>. She is also credited with discovering that tumor cells induce intracellular nutrient<\/a> scavenging by autophagy<\/a>, which enhances metabolism, growth, survival, and malignancy<\/a>. <\/p>\n\n\n\n She was born and raised on Long Island, New York, and graduated with a B. S. in biology from the Rensselaer Polytechnic Institute<\/a> in 1977. In 1983, She received a bachelor’s degree in biology from SUNY Stony Brook<\/a>. She was a Damon Runyon postdoctoral fellow<\/a> and researcher at Cold Spring Harbor Laboratory<\/a> before moving to Rutgers University<\/a>, where she helped to create the Rutgers Cancer Institute<\/a>. <\/p>\n\n\n\n Eileen White’s research focuses on finding pathways that allow tumor cells and malignancies to survive, grow, and avoid immune system<\/a> monitoring. The overarching objective is to discover innovative ways of cancer therapy<\/a>. They discovered that adenovirus<\/a> generated a viral homolog of the human BCL-2 oncoprotein<\/a> that inhibited apoptosis by binding and inhibiting pro-apoptotic BCL-2 protein family members by researching how an oncogene encoded by the DNA tumor virus adenovirus promotes oncogenesis<\/a>. These discoveries lead to the realization that resisting apoptosis<\/a> was also one of the hallmarks of cancer. <\/p>\n\n\n\n Eileen White<\/strong> at Facebook<\/strong><\/a><\/p>\n\n\n\n Eileen White<\/strong> at Twitter<\/strong><\/a><\/p>\n\n\n\n Eileen White<\/strong> at Linkedin<\/strong><\/a><\/p>\n\n\n\nWorks<\/strong><\/h2>\n\n\n\n
Social Media <\/strong><\/h2>\n\n\n\n